Temperature control to improve neurological outcomes after cardiac arrest (IPG782)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 January 2024
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)Product type:GuidanceProgramme:NICE guidelinePublished: 14 December 2023
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy (TA913)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 September 2023
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)Product type:GuidanceProgramme:Health technology evaluationPublished: 9 March 2023
Bioresorbable stent implantation to treat coronary artery disease (IPG732)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 3 August 2022
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides (TA805)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 July 2022
MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 5 July 2022Published: 16 November 2011
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 19 May 2021Published: 13 February 2017
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (DG43)Product type:GuidanceProgramme:Diagnostics guidancePublished: 17 March 2021
Acute coronary syndromes (NG185)Product type:GuidanceProgramme:NICE guidelinePublished: 18 November 2020
Drug-eluting stents for the treatment of coronary artery disease (TA152)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 18 November 2020Published: 23 July 2008
Guidance on the use of coronary artery stents (TA71)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 18 November 2020Published: 22 October 2003
High-sensitivity troponin tests for the early rule out of NSTEMI (DG40)Product type:GuidanceProgramme:Diagnostics guidancePublished: 26 August 2020
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention (IPG673)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 June 2020
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease (TA607)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 October 2019
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions (IPG633)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 November 2018
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (DG3)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 6 July 2017Published: 25 January 2012
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 December 2016
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis (CG95)Product type:GuidanceProgramme:Clinical guidelineLast updated: 30 November 2016Published: 24 March 2010
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) (TA351)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome (TA335)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 March 2015
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (TA317)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 July 2014
Endoscopic saphenous vein harvest for coronary artery bypass grafting (IPG494)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 June 2014
Optical coherence tomography to guide percutaneous coronary intervention (IPG481)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 February 2014
Ticagrelor for the treatment of acute coronary syndromes (TA236)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 October 2011
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction (TA73)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 July 2011Published: 26 November 2003
Percutaneous laser coronary angioplasty (IPG378)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 January 2011
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (TA210)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 December 2010
Cardiovascular disease prevention (PH25)Product type:GuidanceProgramme:Public health guidelinePublished: 22 June 2010
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (TA47)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 March 2010Published: 5 September 2002
Percutaneous laser revascularisation for refractory angina pectoris (IPG302)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 May 2009
Transmyocardial laser revascularisation for refractory angina pectoris (IPG301)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 May 2009
Cardiovascular disease: identifying and supporting people most at risk of dying early (PH15)Product type:GuidanceProgramme:Public health guidelinePublished: 24 September 2008
Endoaortic balloon occlusion for cardiac surgery (IPG261)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 May 2008
Totally endoscopic robotically assisted coronary artery bypass grafting (IPG128)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2005
Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency (IPG98)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 October 2004
Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (TA52)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 October 2002
MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgery (MIB323)Product type:AdviceProgramme:Medtech innovation briefingPublished: 20 June 2023
Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome (MIB223)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 August 2020
Optowire for measuring fractional flow reserve (MIB199)Product type:AdviceProgramme:Medtech innovation briefingPublished: 3 December 2019
DuraGraft for preserving vascular grafts (MIB184)Product type:AdviceProgramme:Medtech innovation briefingPublished: 8 May 2019
Kendall DL for ECG monitoring in people having cardiac surgery (MIB177)Product type:AdviceProgramme:Medtech innovation briefingPublished: 18 March 2019
VEST external stent for coronary artery bypass grafts (MIB115)Product type:AdviceProgramme:Medtech innovation briefingPublished: 2 August 2017
Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB53)Product type:AdviceProgramme:Medtech innovation briefingLast updated: 6 July 2017Published: 1 March 2016
Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB54)Product type:AdviceProgramme:Medtech innovation briefingLast updated: 6 July 2017Published: 1 March 2016
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)Product type:AdviceProgramme:Medtech innovation briefingPublished: 29 November 2016
Coronary revascularisation: Cangrelor (ESNM63)Product type:AdviceProgramme:Evidence summaryPublished: 3 November 2015
The PressureWire fractional flow reserve measurement system for coronary artery disease (MIB2)Product type:AdviceProgramme:Medtech innovation briefingPublished: 4 February 2014
Cardiovascular risk assessment and lipid modification (QS100)Product type:Quality standardLast updated: 24 May 2023Published: 4 September 2015
Acute coronary syndromes in adults (QS68)Product type:Quality standardLast updated: 18 November 2020Published: 5 September 2014
Secondary prevention after a myocardial infarction (QS99)Product type:Quality standardPublished: 4 September 2015
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary interventionStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 5 February 2025
Drug-eluting coronary stents for treating coronary artery disease: late-stage assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 12 May 2025
Cardiovascular risk assessment and lipid modificationStatus:In developmentExpected publication date: 23 July 2025
Coronary venous arterialisation in patients with refractory anginaStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Optical Coherence Tomography to guide percutaneous coronary interventionStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Digital platforms to support cardiac rehabilitationStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC
Insertion of a Catheter based intravascular microaxial blood pump for acute heart failureStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Spartan RX point-of-care CYP2C19 testStatus:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC
Zoll ThermoGuard XP for Intravascular Temperature ManagementStatus:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventionsStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: TBC